Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed version/revision indicator has been incremented from “v3.5.2” to “v3.5.3,” reflecting a minor site update without changing the underlying clinical trial content.
    Difference
    0.1%
    Check dated 2026-04-23T21:56:42.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Website revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T12:31:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a disease term and a link to the Genetic and Rare Diseases Information Center; updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T20:20:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2. This is a metadata version update.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:17.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The prior lapse-in-government-funding operating-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T00:27:42.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide funding/operating status notice has been added, and the site version has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:44:14.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.